340B Grantees Need More Scrutiny as Drug Margins Rise, Gilead-funded Study Says

Gilead BGR study
340B contract pharmacy arrangements rose 252% for grantee covered entities between 2017 to 2022 compared to 194% for hospitals, a new drug company-funded study found.

Health centers and other federal grantees’ 340B savings and how they use them need more scrutiny, as these covered entities account for a large chunk of total 340B drug sales and their margins are keeping pace with those of hospitals,

Read More »

340B Advocacy Group CV340B Plans March on Capitol Hill July 12

CV340B
Community Voices for 340B (CV340B) on July 12 is holding its second annual Defend 340B March on Capitol Hill. The first was in August 2022.

340B grassroots group Community Voices for 340B (CV340B) has announced plans to hold its second annual Defend 340B March on Capitol Hill July 12.

A primary goal of the event is to raise awareness among lawmakers about 340B’s importance

Read More »

Bills Filed in New York to Help 340B Providers Hurt by Medicaid Drug Benefit Transfer

Gustavo Rivera
New York State Sen. Gustavo Rivera (D) introduced bills to help 340B providers hurt by the state’s transfer of Medicaid managed care drug benefits to Medicaid fee for service on April 1.

A New York state lawmaker and strong 340B program supporter last week introduced bills to help 340B providers hurt by the state’s transfer of Medicaid managed care drug benefits to Medicaid fee for service on April 1.

Under Medicaid managed

Read More »

Janssen to Pay Refunds for 340B Overcharges in Q2 2020

Janssen
Janssen Biotech is paying refunds for overcharges on certain 340B drugs purchased in the third quarter of 2020.

Drug manufacturer Janssen Pharmaceuticals said last week it would pay refunds for overcharges on 340B drugs purchased in the second quarter of 2020, including top-selling psoriasis drug Stelara.

Janssen, part of Johnson & Johnson, said it owes or may owe

Read More »

Lifestar, Chartwell Announce Refunds for Q4 2022 340B Overcharges

340B refund notices
HRSA recently posted notices on its website of refunds for 340B overcharges from two generic drug manufacturers.

Generic drug manufacturers Lifestar Pharma and Chartwell Pharmaceuticals may owe refunds to 340B covered entities for overcharges on drugs purchased from the companies in the fourth quarter of 2022, according to recent notices posted on the U.S. Health Resources and

Read More »

Ex-GOP Congressman Burton Slams Current GOP Rep. Rosendale’s 340B Bill

Dan Burton
Retired U.S. Rep. Dan Burton (R-Ind.) lauded the 340B program and criticized a current GOP congressman's 340B bill in a newspaper op-ed this week.

Former Republican Congressman Dan Burton (Ind.) called the 340B program “a win for all parties involved” in a Kokomo, Indiana newspaper op-ed this week and said a current House Republican’s 340B bill could deny vulnerable Hoosiers access to care.

Rep.

Read More »

Astellas Notifies 340B Entities for Second Time in 2023 About a Change in Drug’s NDC

Cresemba
Astellas says for 340B replenishment, the new and old NDCs of Cresemba’s 372mg intravenous formulation are interchangable.

Drug maker Astellas will let 340B covered entities count accumulations of an injectable form of its antifungal drug Cresemba under its old National Drug Code toward replenishment of equal quantities under the product’s corresponding new NDC, provided the entities use

Read More »

340B Abuse Claims Raised During House Hearing on Nonprofit Hospitals’ Tax Status

“Right now, there’s no transparency regarding the 340B program,” Johns Hopkins University professor Ge Bai said yesterday at a U.S. House Ways and Means oversight subcommittee hearing.

The 340B program has evolved into a “buy low, sell high” drug pricing system abused by some hospitals that have profits as their main goal, a health policy researcher told lawmakers Wednesday at a U.S. House subcommittee hearing.

The House

Read More »

Iowa Set to Enact Nation’s 25th 340B Nondiscrimination Law

Iowa state capitol
The Iowa Senate last week passed a 340B nondiscrimination bill 49-1, sending it to Gov. Kim Reynolds. The House passed it earlier 98-0.

The Iowa Senate last week passed a House-approved bill banning pharmacy benefit manager and payor discrimination against 340B covered entities and their contract pharmacies, including reimbursing the entities at a lower rate than non-340B providers.

The Senate voted 49-1 on

Read More »

Hospitals Urge Fed. Appeals Court to Uphold Novel Ark. Law Protecting 340B Discounts in Contract Pharmacy Setting

Eighth Circuit Court
PhRMA filed a citation to notify the U.S. Eighth Circuit Court of Appeals in St. Louis that Arkansas is enforcing its 340B contract pharmacy law.

Three groups representing 340B hospitals late last week filed an amicus brief in federal circuit court in support of Arkansas’ novel contract pharmacy law, arguing the law doesn’t conflict with the 340B statute and in fact furthers the goals of

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live